Novavax Aktie
5,62
EUR
+0,22
EUR
+4,06
%
6,50
USD
+0,18
USD
+2,77
%
Es gab keine Analysen zu dieser Aktie in den letzten sechs Monaten.
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| AstraZeneca PLC | 6 | 3 | 0 | 136,60 GBP | +32,21% |
| Bayer | 2 | 7 | 0 | 26,00 EUR | -2,09% |
| BioNTech (ADRs) | 4 | 2 | 0 | 135,33 USD | +28,78% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 2 | 0 | - | - |
| Fresenius Medical Care (FMC) St. | 3 | 5 | 2 | 48,72 EUR | +2,10% |
| Fresenius SE & Co. KGaA (St.) | 8 | 2 | 0 | 49,25 EUR | +16,71% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Inovio Pharmaceuticals Inc | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Moderna Inc | 0 | 2 | 1 | 67,33 USD | +151,23% |
| Novartis AG | 3 | 5 | 1 | 99,75 CHF | +4,54% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 4 | 0 | 29,17 USD | +19,99% |
| Roche AG (Genussschein) | 3 | 3 | 3 | 279,75 CHF | +6,73% |
| Sanofi S.A. | 6 | 3 | 0 | 116,12 EUR | +38,63% |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |